BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3381370)

  • 1. Complications of retroperitoneal lymph node dissection.
    Bihrle R; Donohue JP; Foster RS
    Urol Clin North Am; 1988 May; 15(2):237-42. PubMed ID: 3381370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
    Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
    J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
    Sexton WJ; Wood CG; Kim R; Pisters LL
    J Urol; 2003 Apr; 169(4):1353-6. PubMed ID: 12629359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve-sparing retroperitoneal lymphadenectomy.
    Jewett MA; Groll RJ
    Urol Clin North Am; 2007 May; 34(2):149-58; abstract viii. PubMed ID: 17484920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
    Mosharafa AA; Foster RS; Leibovich BC; Bihrle R; Johnson C; Donohue JP
    J Urol; 2003 Jun; 169(6):2126-8. PubMed ID: 12771733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open retroperitoneal lymph node dissection.
    Richie JP
    Can J Urol; 2005 Feb; 12 Suppl 1():37-9. PubMed ID: 15780163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
    Williams SB; Steele GS; Richie JP
    J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations.
    Rassweiler JJ; Seemann O; Henkel TO; Stock C; Frede T; Alken P
    J Urol; 1996 Sep; 156(3):1108-13. PubMed ID: 8709319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroperitoneal lymph node dissection in testicular cancer.
    Jacobsen NE; Foster RS; Donohue JP
    Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of nerve sparing retroperitoneal lymph node dissection.
    Mezvrishvili Z; Managadze L
    Georgian Med News; 2006 Mar; (132):20-3. PubMed ID: 16636371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer.
    Subramanian VS; Nguyen CT; Stephenson AJ; Klein EA
    Urol Oncol; 2010; 28(5):504-9. PubMed ID: 19097812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH; Stein JP; Skinner DG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissection.
    Chang SS; Smith JA; Girasole C; Baumgartner RG; Roth BJ; Cookson MS
    J Urol; 2002 Jul; 168(1):87-92. PubMed ID: 12050498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients.
    Beck SD; Peterson MD; Bihrle R; Donohue JP; Foster RS
    J Urol; 2007 Aug; 178(2):504-6; discussion 506. PubMed ID: 17561131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma.
    Foster RS; Donohue JP
    J Urol; 2000 Jun; 163(6):1788-92. PubMed ID: 10799183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic laparoscopic retroperitoneal lymph node dissection for non seminomatous testicular tumor.
    Janetschek G; Reissigl A; Peschel R; Hobisch A; Bartsch G
    Ann Urol (Paris); 1995; 29(2):81-90. PubMed ID: 7646002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postchemotherapy laparoscopic retroperitoneal lymph node dissection: evaluation of complications.
    Permpongkosol S; Lima GC; Warlick CA; Allaf ME; Varkarakis IM; Bagga HS; Kohanim S; Kavoussi LR
    Urology; 2007 Feb; 69(2):361-5. PubMed ID: 17320678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
    Mosharafa AA; Foster RS; Koch MO; Bihrle R; Donohue JP
    J Urol; 2004 May; 171(5):1839-41. PubMed ID: 15076289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.